glp 1 drugs Patients' Use GLP-1 for Weight Loss, Benefit Gains Comparing Ozempic, Wegovy and Other

This means it activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, a hormone pathway that helps the body release insulin after eating, which may lead to greater effects on blood sugar and weight loss compared to single GLP-1 agonists

included calendar year in the propensity score

We operationalized engagement based on 3 key behaviors that the clinical and research teams identified as most likely to drive meaningful outcomes

conducted a collaborative meta-analysis of randomised, double-blind, placebo-controlled, event-driven outcome trials within the SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists Consortium (SMART-C Meta-Analysis, 2024)[21]

Eur J Heart Fail 19:6977